AMRX 8-K 2026-01-13

Amneal Pharmaceuticals, Inc. (AMRX) 8-K dated 2026-01-13 — accession 0001723128-26-000003. This URL is the filing, not the AMRX hub.

Amneal Pharmaceuticals, Inc. (AMRX) is a drug manufacturers - specialty & generic company listed on NASDAQ.

Amneal Pharmaceuticals, Inc. filed a 8-K on 2026-01-13. Accession 0001723128-26-000003.

Cached items: 2.02, 7.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported AMRX revenue for 2025-12-31 was $3.02B. Net income was $72.1M. Revenue was up 8.0% from 2024-12-31 to 2025-12-31. AMRX currently screens at market cap $5.19B.

Not investment advice. The AMRX SEC hub lists recent forms. The stock page is the research view.